Ali Reza Khosravi | Immunology and Microbiology | Best Researcher Award

Posted on by ScienceFather

Ali Reza Khosravi | Immunology and Microbiology | Best Researcher Award

Prof Dr Ali Reza Khosravi, University of Tehran, Iran

Dr. Ali Reza Khosravi, DVM, MPH, PhD, is a Professor at the University of Tehran, leading its Mycology Research Center. His expertise in medical mycology spans fungal immunology, antifungal drugs, and immunomodulatory agents. Dr. Khosravi has authored several influential books on fungal infections and allergies and is a distinguished member of ISHAM and Iranian societies in immunology and mycology. Recognized with multiple awards, including Iran’s top researcher accolades, he continues to advance fungal immunology globally. πŸ„

Publication profile

orcid

Education

Dr. Ali Reza Khosravi holds a diverse academic background. He earned his DVM from the University of Tehran in 1985, focusing on fish skin ulcer caused by Aspergillus species under the guidance of Prof. B. Mokhayer. Dr. Khosravi then pursued an MPH from Tehran University of Medical Sciences in 1988. In 1992, he completed his PhD in Medical Mycology at Tehran University of Medical Sciences, researching dermatophyte antigens and immunity to dermatophytosis under the supervision of Prof. M. Emami and Prof. H. Tadjbakhsh. He further honed his expertise through fellowships in Fungal Immunology at the University of Sao Paolo, Brazil, and Fungal Allergy and Immunology at the University of Leeds, UK. πŸ„

Experience

Since 1992, Dr. Ali Reza Khosravi has been dedicated to academia at the University of Tehran, Iran. Starting as an Assistant Professor from 1992 to 1996, he advanced to the position of Associate Professor from 1996 to 2001. Since 2001, he has held the prestigious title of Professor, continuing his impactful research and mentorship at the University. Dr. Khosravi’s career spans over three decades of commitment to mycology research, focusing on fungal immunology, antifungal drugs, and immunomodulatory agents. His contributions have earned him recognition as a leading authority in his field, bolstered by numerous awards and affiliations with international mycological societies. πŸŽ“

Honors

Dr. Ali Reza Khosravi has been recognized with prestigious awards throughout his career, underscoring his exceptional contributions to veterinary and medical mycology. His accolades include the Award of the First Ranked Professor in Iran (2008), the Award of the First Ranked Researchman in Iran (2004), and multiple honors as the top researcher at the University of Tehran (2001, 2004). Dr. Khosravi’s scholarly achievements were also celebrated internationally, with awards for Best Presented Papers at the International Veterinary Congress in Rio De Janeiro, Brazil (1992), and Top Presented Papers at the Asia Pacific International Congress in Penang, Malaysia (2004). πŸ†

Research focus

Dr. Ali Reza Khosravi’s research focuses on diverse aspects of medical mycology and fungal immunology, exploring antifungal agents, immunomodulatory therapies, and the susceptibility profiles of fungal pathogens. His contributions span from investigating the chemical compositions of natural compounds against fish fungal infections to evaluating the antifungal potentials of essential oils and their combinations with conventional drugs. Dr. Khosravi’s work is pivotal in understanding fungal diseases’ mechanisms and developing novel therapeutic approaches πŸ„.

Publication top notes

Biomimetic functionalized metal organic frameworks as multifunctional agents: Paving the way for cancer vaccine advances

Disseminated protothecosis: Case report and review of the literature

Actinomyces in Hand: An Unusual Cause of Osteomyelitis

Antifungal susceptibility profile of yeasts isolated from the oral cavity of cats

Chemical composition and in vitro antifungal activity of Sambucus ebulus and Actinidia deliciosa on the fish pathogenic fungus, Saprolegnia parasitica

Potential antifungal impact of citral and linalool administered individually or combined with fluconazole against clinical isolates of Candida krusei

Intrinsic Oncolytic Activity of Hoshino Mumps Virus Vaccine Strain Against Human Fibrosarcoma and Cervical Cancer Cell Lines

The efficacy of zymosan in pro-inflammatory cytokine production by peritoneal macrophages of melanoma-bearing mice

Chemical composition and antifungal activity of Satureja hortensis L. essentiall oil against planktonic and biofilm growth of Candida albicans isolates from buccal lesions of HIV(+) individuals.

Chitin-Induced Airway Epithelial Cell Innate Immune Responses Are Inhibited by Carvacrol/Thymol

Peng Xiao | Macrophage Biology | Best Researcher Award

Posted on by ScienceFather

Assoc Prof Dr. Peng Xiao | Macrophage Biology | Best Researcher Award

Assoc Prof Dr. Peng Xiao, Zhejiang University, China

Dr. Peng Xiao, Assoc. Prof., is a distinguished immunologist specializing in Macrophage Biology. Holding an MD from Zhejiang University, he completed postdoctoral research at Harvard University before joining Zhejiang University as Assistant Professor, later promoted to Associate Professor. Dr. Xiao is a member of prestigious organizations including The American Association of Immunologists, Society for Mucosal Immunology, and Chinese Society for Immunology. He serves on the Editorial Board of the Journal of Leukocyte Biology. Passionate about unraveling mysteries of the immune system 🦠, Dr. Xiao’s research significantly contributes to understanding macrophage function and immunological processes.

Publication Profile:

Scopus

Orcid

Education:

Dr. Peng Xiao’s academic journey reflects a commitment to advancing knowledge in immunology. Beginning with his MD from Zhejiang University’s Institute of Immunology from 2011 to 2015 πŸŽ“, he laid a solid foundation in medical science. Eager to delve deeper into research, he pursued a postdoctoral position at Harvard University’s Medicine School from 2019 to 2021 πŸ₯. During this time, he honed his expertise in macrophage biology, a field he’s passionate about.Returning to Zhejiang University in 2015, Dr. Xiao transitioned to the role of Assistant Professor, where he actively contributed to both teaching and research. Recognized for his exceptional dedication and contributions to the field, he was promoted to Associate Professor in 2019, reaffirming his position as a respected figure in academia πŸ“š.

Employment:

Dr. Peng Xiao’s professional journey spans across two renowned institutions, showcasing his dedication to advancing research in immunology. At Zhejiang University in Hangzhou, China 🏫, Dr. Xiao has been deeply engaged in academia, contributing significantly as an Associate Professor. His tenure at this esteemed university underscores his commitment to education and research, where he actively participates in shaping the next generation of scholars and delving into the complexities of immunological science.In parallel, Dr. Xiao’s pursuit of excellence led him to Harvard Medical School in Boston, Massachusetts πŸ‡ΊπŸ‡Έ, where he undertook a prestigious postdoctoral position. Immersed in the vibrant academic environment of one of the world’s leading medical institutions, Dr. Xiao furthered his expertise in immunology, particularly in the field of macrophage biology. His time at Harvard Medical School not only enriched his knowledge but also facilitated collaborations and networking opportunities with leading experts in the field.Through his employment at both Zhejiang University and Harvard Medical School, Dr. Xiao demonstrates his unwavering dedication to advancing scientific knowledge and making meaningful contributions to the field of immunology. His experiences at these distinguished institutions have undoubtedly shaped his trajectory as a respected researcher and educator.

Research Focus:

Dr. Peng Xiao’s research focuses on immunological mechanisms and their implications in various diseases, particularly emphasizing macrophage biology. His work spans understanding the role of macrophages in gut homeostasis, melanoma progression, and pulmonary fibrosis, among other conditions. Through his investigations, Dr. Xiao has elucidated pathways involving cytokines like TNF-Ξ± and IL-10, shedding light on potential therapeutic targets for inflammatory disorders and cancer. With a keen interest in unraveling the complexities of the immune system 🧬, his contributions pave the way for novel interventions and treatments to alleviate disease burden and improve patient outcomes.

Publication Top Notes:

  1. Mannose metabolism normalizes gut homeostasis by blocking the TNF-Ξ±-mediated proinflammatory circuit – Published in 2022 πŸ“š
  2. PGAM5: A necroptosis gene associated with poor tumor prognosis that promotes cutaneous melanoma progression – Published in 2022 🩺
  3. Macrophage orchestration of epithelial and stromal cell homeostasis in the intestine – Published in 2022 🦠
  4. Myeloid Fbxw7 Prevents Pulmonary Fibrosis by Suppressing TGF-Ξ² Production – Published in 2022 🫁
  5. Induction of co-inhibitory molecule CTLA-4 by human papillomavirus E7 protein through downregulation of histone methyltransferase JHDM1B expression – Published in 2019 🦠
  6. Phosphatase Shp2 exacerbates intestinal inflammation by disrupting macrophage responsiveness to interleukin-10 – Published in 2019 🧫
  7. USP16-mediated deubiquitination of calcineurin A controls peripheral T cell maintenance – Published in 2019 πŸ”¬
  8. Myeloid-restricted ablation of Shp2 restrains melanoma growth by amplifying the reciprocal promotion of CXCL9 and IFN-Ξ³ production in tumor microenvironment – Published in 2018 🦠
  9. Cellular Phenotypic Analysis of Macrophage Activation Unveils Kinetic Responses of Agents Targeting Phosphorylation – Published in 2017 🧬
  10. E3 ligase FBXW7 is critical for RIG-I stabilization during antiviral responses – Published in 2017 πŸ¦